Aug 25, 2026 07:00AM
May 27, 2026 07:38AM
May 27, 2026 07:00AM
May 20, 2026 07:00AM
Mar 23, 2026 07:00AM
Mar 16, 2026 07:00AM
Nov 24, 2025 07:37AM BioLineRx (BLRX) Tops Q3 EPS by 8c
Nov 24, 2025 07:00AM
Nov 18, 2025 07:00AM
Aug 14, 2025 07:14AM
Aug 14, 2025 07:00AM
Aug 7, 2025 07:00AM
May 28, 2025 06:57AM
May 27, 2025 04:22PM BioLineRx (BLRX) Tops Q1 EPS by 10c
May 27, 2025 07:00AM
May 20, 2025 07:00AM
Apr 1, 2025 04:31PM
Mar 31, 2025 07:00AM
Mar 24, 2025 07:00AM
Nov 26, 2024 06:59AM
Nov 25, 2024 07:05AM BioLineRx (BLRX) Tops Q3 EPS by 4c
Nov 25, 2024 07:00AM
Nov 20, 2024 07:19AM
Aug 15, 2024 07:01AM
Aug 15, 2024 07:00AM
Aug 8, 2024 07:00AM
May 28, 2024 07:06AM
May 28, 2024 07:00AM BioLineRx Reports First Quarter 2024 Financial Results and Recent Corporate and Portfolio Updates
May 22, 2024 07:00AM
Mar 26, 2024 07:00AM
Mar 20, 2024 07:00AM
Nov 20, 2023 07:02AM
Nov 20, 2023 07:00AM
Nov 13, 2023 07:00AM
Aug 30, 2023 07:10AM BioLineRx (BLRX) Tops Q2 EPS by 7c
Aug 30, 2023 07:00AM
Aug 22, 2023 07:00AM
May 24, 2023 07:10AM
May 24, 2023 07:00AM
May 17, 2023 07:00AM
Mar 22, 2023 07:00AM
Mar 15, 2023 07:00AM BioLineRx to Report 2022 Annual Financial Results on March 22, 2023
Mar 1, 2023 09:00PM
Feb 24, 2023 09:00PM
Feb 19, 2023 09:00PM
Feb 13, 2023 09:00PM
Feb 8, 2023 09:00PM
Feb 3, 2023 09:00PM
Jan 29, 2023 09:00PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against BioLineRx, Enovix, Southwest Airlines, and Y-mAbs and Encourages Investors to Contact the Firm
Jan 23, 2023 09:00PM

1,223,223 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All